Presently, Chlorion is developing two small molecule leads for the treatment of neuropathic pain and epilepsy.
Learn MoreChlorion’s leadership is composed of leading experts in the role of chloride homeostasis in neurological dysfunction and CNS drug discovery, in addition to seasoned biopharmaceutical executives.
Learn MoreDecember 15th, 2008.
Chlorion Pharma Inc. Closes a Financing of $4M in Convertible Debt.